Ocular Therapeutix: Q3 Earnings Insights

Comments
Loading...

Ocular Therapeutix OCUL reported its Q3 earnings results on Monday, November 8, 2021 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

Ocular Therapeutix their estimated earnings by 11.54%, reporting an EPS of $-0.23 versus an estimate of $-0.26, which surprised analysts.

Revenue was up $6,277,000 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.04, which was followed by a 2.42% increase in the share price the next day.

Here's a look at Ocular Therapeutix's past performance:

 

Quarter Q2 2021 Q1 2021 Q4 2020 Q3 2020
EPS Estimate -0.21 -0.21   -0.24
EPS Actual -0.25 -0.24 -1.21 -0.21
Revenue Estimate 11.60M 7.64M 9.76M 5.49M
Revenue Actual 11.72M 7.34M 7.35M 5.88M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

OCUL Logo
OCULOcular Therapeutix Inc
$7.311.95%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
28.12
Growth
-
Quality
-
Value
27.17
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In: